Cost-Effectiveness of PET Directed Versus Combined Modality Therapy for Early-Stage Favorable Hodgkin's Lymphoma

Clayton P. Smith, Bethel Adefres, Eric M. Chang, Tina Q. Huang, Neil Parikh, Ann Raldow

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Cost-Effectiveness of PET Directed Versus Combined Modality Therapy for Early-Stage Favorable Hodgkin's Lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences